stay updated with our newsletter

Close this search box.

Eight Supplements for Sleep and Relaxation Support

Sleep and Relaxation Support

As mentioned in previous articles, phosphatidylserine, ashwagandha, and melatonin, provide a wide array of nutraceuticals with evidence that backs their use for sleep and relaxation support. In clinical practice however, we often lack the time to do a deep dive into the data behind these tools and tend to avoid using supplements we do not have time to fully research. A short summary of the mechanisms of action and clinical data supporting a variety of natural substances that promote relaxation and/or sleep is presented below.

Gamma Aminobutyric Acid for Sleep and Relaxation Support

The balance of the neurotransmitters glutamate and gamma-aminobutyric acid (GABA) in the central nervous system plays an important role in cortical excitability.1 An appropriate balance of excitation and inhibition is necessary for healthy sleep, a balanced mood, memory, and cognitive processes. Glutamate is the main excitatory neurotransmitter while GABA is the main inhibitory neurotransmitter. Lower GABA concentrations have been shown to be associated with poor sleep quality and have been demonstrated in individuals with major depressive disorder and higher trait and state anxiety.2,3,4 GABA also helps to reduce the response to fear or anxiety-provoking stimuli.5 Many sedatives bind or stimulate GABA receptors, reinforcing the importance of this neurotransmitter for sleep.6

In individuals with attention deficit hyperactivity disorder (ADHD), significantly lower GABA levels have been observed in a region of the brain known as the anterior cingulate cortex which is associated with decision making, emotion, and impulse control.7 Additionally, measures of impulsivity were shown to be negatively related to GABA levels, that is, individuals with the lower GABA levels were more impulsive. Glutamate, on the other hand, has been shown to be twice as high in children with ADHD, tipping the balance to that of an excitatory state.8 Supplemental administration of GABA has been shown to significantly increase alpha wave patterns in humans, accompanied by reduced levels of anxiety.9,10Alpha waves predominantly occur during wakeful relaxation, and are present during activities such as meditation.11 Orally, GABA is usually well tolerated but some may experience side effects such as nausea, tiredness, and a mild decrease in blood pressure at higher dosages.12,13

Although the ability of supplemental GABA to cross the blood-brain barrier (BBB) under normal conditions is questionable, there is evidence of a specialized GABA transporter in the BBB.14 There also are many settings in which the permeability of the BBB is increased, including with exposure to inflammatory agents such as histamine and bradykinin.15 It also has been proposed that the effects seen clinically with GABA are due to the binding of receptors in the enteric nervous system, and are modulated by the vagus nerve.16 Additionally, liposomal delivery systems have been shown to facilitate transport across the BBB and increase availability of therapeutic agents in the central nervous system.17


Green tea is well known for its high amounts of antioxidants, particularly one known as epigallocatechin gallate or EGCG. However, green tea also contains a high amount of an amino acid known as L-theanine. L-theanine is widely used and studied in Japan,18 a culture particularly known for their tea consumption. L-theanine has been observed to promote relaxation and reduce stress by a variety of possible mechanisms, with clinical evidence also showing these benefits.

Studies have shown that L-theanine increases alpha-wave activity in the brain,19 as well as the levels of serotonin, dopamine and GABA.20,21L-theanine has been shown to be neuroprotective, in part by having an antagonistic effect on glutamate subtype AMPA receptors,22,23also increasing glutathione as well as its related antioxidant enzymes (superoxide dismutase and catalase) under stressful settings.24 It also supports nerve growth and new pathways via increasing levels of brain-derived neurotrophic factor (BDNF).25

Clinically, supplementation with L-theanine has been shown to have a relaxing effect, reducing anxiety as well as heart rate and blood pressure in acute stressful events and during mentally challenging tasks.26,27,28 L-theanine has been shown to reduce subjective experiences of stress and salivary α-amylase activity, a marker of sympathetic nervous system activity and the “fight or flight” response, during academic challenges.29 At a dosage of 200 mg daily, L-theanine has been shown to significantly reduce emotional symptoms of premenstrual syndrome, including irritability, anger, mood swings, and crying.30 In children with ADHD, L-theanine has also been shown to improve aspects of sleep quality and has been studied and found safe to be used for this purpose at doses of 200 mg twice daily.31 L-theanine continues to be studied for the impacts it may have on learning and memory, attention, mood, and even other mental health conditions such as schizophrenia.32 Orally, L-theanine has been shown to be well tolerated.


5-hydroxytryptophan (5-HTP) is an amino acid that is produced in the body from the essential amino acid tryptophan. 5-HTP is the immediate precursor to serotonin, which converts to melatonin. The enzyme 5-hydroxytryptophan decarboxylase converts 5-HTP to serotonin and requires vitamin B6 (pyridoxine).33,34 In animals, this reaction has been shown to occur primarily in the brain, liver, kidney and adrenals.35,36  5-HTP is well absorbed orally, and easily crosses the blood brain barrier.37

In children, at a dosage of 2 mg/kg at bedtime, 5-HTP has been shown to significantly reduce the occurrence of night terrors. There were no adverse effects seen with the treatment, which continued for 6 months, and EEG reading were observed to be normal.38 In another study in a pediatric population having headaches in association with sleep disorders, 5-HTP was also found to improve sleep, particularly frequent awakenings.39 In adults with normal healthy sleep, 5-HTP was observed to increase rapid eye movement portion of sleep.40

5-HTP has been studied in different settings of acute anxiety and shown to significantly reduce the reaction to panic challenge in patients with panic disorders.41 In patients diagnosed with anxiety disorders, 5-HTP has been shown to lead to a moderate reduction of symptoms as measured by the 90-item symptoms checklist (SCL-90) and the State Scale of the Spielberger State-Trait Anxiety Inventory.42 There is some evidence in clinical studies for the treatment of depression, however the quality and size of studies are limited.43,44 The combination of GABA and L-theanine has been studied in invertebrate and vertebrate models, and shown to significantly regulate the sleep latency and duration as well as significantly increase the sleep quality as compared to single administration of either amino acid.45,46 Long-term administration also was observed to increase levels of GABA and the GABAA receptor.

Side effects that can occur with higher dosages of 5-HTP can include nausea, vomiting, and diarrhea. 5-HTP conversion to serotonin peripherally has the potential to increase gut motility. Serotonin syndrome, while a possibility, has rarely been reported.47 Clinical studies have been performed using 5-HTP in combination with tricyclic antidepressants, monoaminoxidase inhibitors,48 selective serotonin reuptake inhibitors,49 and serotonin syndrome was not seen in any of these settings. However, the small sizes of these studies should be considered and the possibility of this syndrome closely monitored for especially if used in combination with these medications.

Dosages and mechanisms for these and other supportive nutrients which have been studied in the settings of sleep and relaxation are listed below. These, and all supplements, should be used with caution and consider the interactions that may exist with medications, as well as the overall health of the individual.

Nutrient Dosage Mechanism
Melatonin 0.75 – 15 mg at bedtime, gradually increasing dosage if needed Endogenous hormone that promotes sleep
L-theanine Children and adults: Up to 400 mg daily, in divided dosages Increases alpha-wave activity as well as the neurotransmitters serotonin and GABA
GABA 100 – 1500 mg daily Inhibitory neurotransmitter, increases alpha-wave patterns in the brain
Phosphatidylserine 200 – 400 mg daily50,51 Reduces serum cortisol levels52
Ashwagandha 125 – 250 mg once or twice daily Reduces serum cortisol levels,53 GABA agonist54
5-HTP Children: 2 mg/kg per day at bedtime

Adults: 50 – 300 mg at bedtime

Precursor to serotonin and melatonin, increases REM sleep
Pyridoxal-5-phosphate (B6) 10 – 50 mg in combination with other sleep supportive nutrients Coenzyme of 5-hydroxytryptophan decarboxylase which converts 5-HTP to serotonin
Magnolia bark extract 200 – 400 mg Anxiolytic, GABAA receptor agonist55,56
Dr. Decker is a Naturopathic Doctor, graduating with honors from the National College of Natural Medicine (now the National University of Natural Medicine) in Portland, Oregon. Dr. Decker sees patients at her office in Portland, OR, as well as remotely, with a focus on gastrointestinal disease, mood imbalances, eating disorders, autoimmune disease, and chronic fatigue. Prior to becoming a naturopathic physician, Dr. Decker was an engineer, and obtained graduate degrees in biomedical and mechanical engineering from the University of Wisconsin-Madison and University of Illinois at Urbana-Champaign respectfully.  Dr. Decker continues to enjoy academic research and writing and uses these skills to support integrative medicine education as a writer and contributor to various resources. Dr. Decker supports Allergy Research Group® as a member of their education and product development team.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.


[1] Petroff OA. GABA and glutamate in the human brain. Neuroscientist. 2002 Dec;8(6):562-73.
[2] Meyerhoff DJ, et al. Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality. Sleep. 2014;37(5):893-900.
[3] Pehrson AL, Sanchez C. Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants. Drug Des Devel Ther. 2015;9:603-24.
[4] Rosso IM, et al. Insula and anterior cingulate GABA levels in posttraumatic stress disorder: preliminary findings using magnetic resonance spectroscopy. Depress Anxiety. 2014;31(2):115-23.
[5] Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007;164(10):1476-88.
[6] Gottesmann C. GABA mechanisms and sleep. Neuroscience. 2002;111(2):231-9.
[7] Ende G, et al. Impulsivity and Aggression in Female BPD and ADHD Patients: Association with ACC Glutamate and GABA Concentrations. Neuropsychopharmacology. 2016 Jan;41(2):410-8.
[8] Gilgun, JF. The NEATS: A Child & Family Assessment. Creat Space Publishing, USA, 2011.
[9] Abdou AM, et al. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors. 2006;26(3):201-8.
[10] Yoto A, et al. Oral intake of γ-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks. Amino Acids. 2012;43(3):1331-7.
[11] Khare KC, Nigam SK. A study of electroencephalogram in meditators. Indian J Physiol Pharmacol. 2000;44(2):173-8.
[12] Loeb C, et al. Preliminary evaluation of the effect of GABA and phosphatidylserine in epileptic patients. Epilepsy Res. 1987 May;1(3):209-12.
[13] Inoue K, et al. Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr. 2003 Mar;57(3):490-5.
[14] Kakee A, et al. Efflux of a suppressive neurotransmitter, GABA, across the blood-brain barrier. J Neurochem. 2001;79(1):110-8.
[15] Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol. 2000 Apr;20(2):131-47.
[16] Boonstra E, et al. Neurotransmitters as food supplements: the effects of GABA on brain and behavior. Front Psychol. 2015;6:1520.
[17] Alyautdin R, et al. Nanoscale drug delivery systems and the blood-brain barrier. Int J Nanomedicine. 2014;9:795-811
[18] Nobre AC, et al. L-theanine, a natural constituent in tea, and its effect on mental state. Asia Pac J Clin Nutr. 2008;17 Suppl 1:167-8.
[19] Nobre AC, et al. L-theanine, a natural constituent in tea, and its effect on mental state. Asia Pac J Clin Nutr. 2008;17 Suppl 1:167-8.
[20] Nathan PJ, et al. The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother. 2006;6(2):21-30.
[21] Yokogoshi H, et al. Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res. 1998;23(5):667-73.
[22] Takeshima M, Miyazaki I, Murakami S, et al. l-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes. J Clin Biochem Nutr. 2016 Sep;59(2):93-99.
[23] Kakuda T. Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction. Pharmacol Res. 2011 Aug;64(2):162-8.
[24] Tian X, et al. Protective effect of l-theanine on chronic restraint stress-induced cognitive impairments in mice. Brain Res. 2013 Mar 29;1503:24-32.
[25] Wakabayashi C, et al. Behavioral and molecular evidence for psychotropic effects in L-theanine. Psychopharmacology (Berl). 2012;219(4):1099-109.
[26] Lu K, et al. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Hum Psychopharmacol. 2004;19(7):457-65.
[27] Kimura K, et al. L-Theanine reduces psychological and physiological stress responses. Biol Psychol. 2007;74(1):39-45.
[28] Yoto A, et al. Effects of L-theanine or caffeine intake on changes in blood pressure under physical and psychological stresses. J Physiol Anthropol. 2012;31:28.
[29] Unno K, et al. Anti-stress effect of theanine on students during pharmacy practice: Positive correlation among salivary α-amylase activity, trait anxiety and subjective stress. Pharmacol Biochem Behav. 2013;111:128-35.
[30] Timmcke JQ, et al. Efficacy and Short-Term Safety of L-Theanine in Randomized, Double-Blind, Parallel-Group Study. The FASEB Journal. 2008 Apr 1;22 (Supplement).
[31] Lyon MR, Kapoor MP, Juneja LR. The effects of L-theanine (Suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): a randomized, double-blind, placebo-controlled clinical trial. Altern Med Rev. 2011;16(4):348-54.
[32] Lardner AL. Neurobiological effects of the green tea constituent theanine and its potential role in the treatment of psychiatric and neurodegenerative disorders. Nutr Neurosci. 2014 Jul;17(4):145-55.
[33] Hartvig P, et al. Pyridoxine effect on synthesis rate of serotonin in the monkey brain measured with positron emission tomography. J Neural Transm Gen Sect. 1995;102(2):91-7.
[34] Rahman MK, et al. Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats. Jpn J Pharmacol. 1982 Oct;32(5):803-11.
[35] Rahman MK, et al. Aromatic L-amino acid decarboxylase activity in central and peripheral tissues and serum of rats with L-DOPA and L-5-hydroxytryptophan as substrates. Biochem Pharmacol. 1981 Mar 15;30(6):645-9.
[36] Bouchard S, et al. Biochemical properties and kinetic parameters of dihydroxyphenylalanine–5-hydroxytryptophan decarboxylase in brain, liver, and adrenals of cat. Can J Biochem. 1979 Jul;57(7):1014-8.
[37] Birdsall TC. 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Altern Med Rev. 1998 Aug;3(4):271-80.
[38] Bruni O, et al. L-5-Hydroxytryptophan treatment of sleep terrors in children. Eur J Pediatr. 2004 Jul;163(7):402-7.
[39] De Giorgis G, et al. Headache in association with sleep disorders in children: a psychodiagnostic evaluation and controlled clinical study–L-5-HTP versus placebo. Drugs Exp Clin Res. 1987;13(7):425-33.
[40] Wyatt RJ, et al. Effects of 5-hydroxytryptophan on the sleep of normal human subjects. Electroencephalogr Clin Neurophysiol. 1971 Jun;30(6):505-9.
[41] Schruers K, et al. Acute L-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients. Psychiatry Res. 2002 Dec 30;113(3):237-43.
[42] Kahn RS, et al. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int Clin Psychopharmacol. 1987 Jan;2(1):33-45.
[43] Shaw K, et al. Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database Syst Rev. 2002;(1):CD003198.
[44] Turner EH, et al. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther. 2006 Mar;109(3):325-38.
[45] Hong KB, et al. Sleep-promoting effects of a GABA/5-HTP mixture: Behavioral changes and neuromodulation in an invertebrate model. Life Sci. 2016 Apr 1;150:42-9.
[46] Hong KB, et al. Sleep-promoting effects of the GABA/5-HTP mixture in vertebrate models. Behav Brain Res. 2016 Sep 1;310:36-41.
[47] Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol. 1997 Jun;17(3):208-21.
[48] Nicolodi M, Sicuteri F. Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy. Adv Exp Med Biol. 1996;398:373-9.
[49] Meltzer H, et al. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder. Neuropsychopharmacology. 1997 Jul;17(1):1-11.
[50] Benton D, et al. The influence of phosphatidylserine supplementation on mood and heart rate when faced with an acute stressor. Nutr Neurosci. 2001;4(3):169-78.
[51] Hellhammer J, et al. A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study. Lipids Health Dis. 2014 Jul 31;13:121.
[52] Hellhammer J, et al. A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study. Lipids Health Dis. 2014 Jul 31;13:121.
[53] Choudhary D, et al. Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract: A Double-Blind, Randomized, Placebo-Controlled Trial. J Evid Based Complementary Altern Med. 2017 Jan;22(1):96-106.
[54] Candelario M, et al. Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors. J Ethnopharmacol. 2015 Aug 2;171:264-72.
[55] Chen CR, et al. Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, induces sleep via the benzodiazepine site of GABAA receptor in mice. Neuropharmacology. 2012 Nov 1;63(6):1191-9.
[56] Kuribara H, et al. The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark. J Pharm Pharmacol. 2000 Nov;52(11):1425-9.


Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.